These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
73 related articles for article (PubMed ID: 23808295)
41. Conclusions: chronic pain studies of lidocaine patch 5% using the Neuropathic Pain Scale. Argoff CE Curr Med Res Opin; 2004; 20 Suppl 2():S29-31. PubMed ID: 15563744 [TBL] [Abstract][Full Text] [Related]
42. Switching from pathogenetic treatment with alpha-lipoic acid to gabapentin and other analgesics in painful diabetic neuropathy: a real-world study in outpatients. Ruessmann HJ; J Diabetes Complications; 2009; 23(3):174-7. PubMed ID: 18403218 [TBL] [Abstract][Full Text] [Related]
43. Sympathetic blockade and amitriptyline in the treatment of reflex sympathetic dystrophy. Karakurum G; Pirbudak L; Oner U; Gulec A; Karadasli H; Satana T Int J Clin Pract; 2003 Sep; 57(7):585-7. PubMed ID: 14529058 [TBL] [Abstract][Full Text] [Related]
44. Management of neuropathic pain with methylprednisolone at the site of nerve injury. Eker HE; Cok OY; Aribogan A; Arslan G Pain Med; 2012 Mar; 13(3):443-51. PubMed ID: 22313580 [TBL] [Abstract][Full Text] [Related]
45. Predictors of response to treatment with actovegin for 6 months in patients with type 2 diabetes and symptomatic polyneuropathy. Ziegler D; Edmundson S; Gurieva I; Mankovsky B; Papanas N; Strokov I J Diabetes Complications; 2017 Jul; 31(7):1181-1187. PubMed ID: 28438471 [TBL] [Abstract][Full Text] [Related]
46. Risk factors for depression and anxiety in painful and painless diabetic polyneuropathy: A multicentre observational cross-sectional study. Kec D; Rajdova A; Raputova J; Adamova B; Srotova I; Nekvapilova EK; Michalcakova RN; Horakova M; Belobradkova J; Olsovsky J; Weber P; Hajas G; Kaiserova M; Mazanec R; Potockova V; Ehler E; Forgac M; Birklein F; Üçeyler N; Sommer C; Bednarik J; Vlckova E Eur J Pain; 2022 Feb; 26(2):370-389. PubMed ID: 34592017 [TBL] [Abstract][Full Text] [Related]
47. Effect of intravenous versus subcutaneous insulin delivery on the intensity of neuropathic pain in diabetic subjects. Rokicka D; Wróbel M; Szymborska-Kajanek A; Adamczyk-Sowa M; Bożek A; Pierzchała K; Strojek K Endokrynol Pol; 2015; 66(3):237-43. PubMed ID: 26136133 [TBL] [Abstract][Full Text] [Related]
48. [Long-term effect of 3-week intravenous alpha-lipoic acid administration in symptomatic diabetic polyneutropathy with clinical manifestations]. Ametov AS; Novosadova MV; Barinov AN; Samigullin R; Trischler HJ Ter Arkh; 2010; 82(12):61-4. PubMed ID: 21516742 [TBL] [Abstract][Full Text] [Related]
50. Patient perspectives on peripheral neuropathic pain experience within the community. Singh-Franco D; Jacobs RJ Diabetes Metab Syndr; 2017 Nov; 11 Suppl 1():S243-S246. PubMed ID: 28057506 [TBL] [Abstract][Full Text] [Related]
51. [Compression of nerves and senses: ipidacrine as the light at the end of the tunnel]. Merkulov YA; Magomedova AM; Biglova AN; Gamburg AM; Tashanova BA; Merkulova DM Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(2):31-37. PubMed ID: 33728848 [TBL] [Abstract][Full Text] [Related]
54. [Dynamics of neurologic disturbances on the background of combined therapy in patients with type 2 diabetes]. Gatckikh IV; Brickman IN; Gazenkampf KA; Petrova MM; Veselova OF; Shalda TP; Narkevich AN; Potupchik TV Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(6):31-36. PubMed ID: 30040798 [TBL] [Abstract][Full Text] [Related]
55. [Effectiveness of cortexin in the complex treatment of patients with chronic alcohol encephalopathy and polyneuropathy]. Solov'ev AG; Elistratova TV Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(4):48-51. PubMed ID: 20517210 [TBL] [Abstract][Full Text] [Related]
56. [Painful diabetic polyneuropathy: focus on life quality improvement of patients]. Shchepankevich LA; Tanashyan MM; Nikolaev YA; Novikova EG; Pinhasov BB; Pervuninskaya MA; Antonova KV Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(5):76-79. PubMed ID: 31317893 [TBL] [Abstract][Full Text] [Related]
57. Risk factors for neuropathic pain in diabetes mellitus. Hébert HL; Veluchamy A; Torrance N; Smith BH Pain; 2017 Apr; 158(4):560-568. PubMed ID: 27941499 [No Abstract] [Full Text] [Related]
58. [Quality of life of patients with diabetic polyneuropathy]. Kapustina LA; Nesterova OS; Boĭko AN; Stulin ID; Antsiferov MB Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(3):47-52. PubMed ID: 19462534 [No Abstract] [Full Text] [Related]
59. Efficiency of Lidocaine Intramuscular and Intraosseous Trigger Point Injections in the Treatment of Residual Chronic Pain after Degenerative Lumbar Spinal Stenosis Decompression Surgery. Al-Zamil M; Kulikova NG; Shnayder NA; Korchazhkina NB; Petrova MM; Mansur TI; Blinova VV; Babochkina ZM; Vasilyeva ES; Zhhelambekov IV J Clin Med; 2024 Sep; 13(18):. PubMed ID: 39336924 [No Abstract] [Full Text] [Related]
60. [Intraosseous blocks in the treatment of symmetrical distal diabetic polyneuropathy]. Sokov EL; Kornilova LE; Artiukov OP Ter Arkh; 2013; 85(4):61-5. PubMed ID: 23808295 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]